Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Reset all filters
01 2Ever Valinject Gmbh
02 1Medac Society For Clinical Specialty Preparations Mbh
03 2Advanz Pharma Limited
04 1Baxter Holding B.V.
05 1Baxter Holding Bv
06 1EISAI LIMITED
07 1Eisai Europe Limited
08 3Eisai Gmbh
09 1Eisai Pharma Ag
10 2Glenmark Arzneimittel Gmbh
11 2Stada Pharmaceuticals Ag
12 1Stada Sl Laboratory
13 1Viatris Limited
14 1Yes Pharmaceutical Development Services Gmbh
15 2Zentiva Ks
Reset all filters
01 4Eribulin
02 7Eribuline Mesylate
03 10Eribulinmesilat
04 1Eribulinum Mesils
Reset all filters
01 1Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
02 20Injectable Solution
03 1Injection fluid, resolution
Reset all filters
01 1Italy
02 1Norway
03 9Spain
04 10Sweden
05 1Switzerland
Reset all filters
01 2Eribulin Advanz Pharma
02 2Eribulin Baxter
03 1Eribulin Ever Pharma
04 1Eribulin Glenmark
05 1Eribulin Medac
06 2Eribulin Stada
07 1Eribulin Stada Arzneimittel Ag
08 1Eribulin Zentiva
09 1Eribulina Ever Pharma
10 1Eribulina Glenmark
11 1Eribulina Viatris
12 1Eribulina Zentiva
13 1Halave
14 5Halaven
15 1Mevlyq
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Ever Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 07/06/2024
Application Number : 20221221000240
Regulatory Info : Approved
Registration Country : Sweden
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Medac
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 30/11/2023
Application Number : 20220930000183
Regulatory Info : Approved
Registration Country : Sweden
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Eribulina Ever Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44MG
Packaging :
Approval Date : 2024-09-30
Application Number : 89838
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Advanz Pharma
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 06/09/2023
Application Number : 20220812000027
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Baxter
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 27/06/2024
Application Number : 20230427000060
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Halaven
Dosage Form : Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 0.88 mg 2 ml 0.44 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Halaven
Dosage Form : Injection fluid, resolution
Dosage Strength : 0.44 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Glenmark
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 30/11/2023
Application Number : 20220930000152
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Stada
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 23/10/2023
Application Number : 20220801000069
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Eribulin Stada Arzneimittel Ag
Dosage Form : Injectable Solution
Dosage Strength : 0.44mg/ml
Packaging :
Approval Date : 01/12/2023
Application Number : 20230321000098
Regulatory Info : Approved
Registration Country : Sweden